"Revolutionary Implantable Device Offers Diabetes Control Without Injections"

MIT engineers have developed an implantable device that carries insulin-producing islet cells and generates its own oxygen by splitting water vapor in the body. When implanted in diabetic mice, the device successfully maintained stable blood glucose levels for at least a month. The researchers aim to create a larger version of the device for testing in humans with Type 1 diabetes. This technology could potentially replace the need for frequent insulin injections and be adapted for other diseases requiring repeated delivery of therapeutic proteins.